Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,913 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia FLT3-ITD patients.
Vignal N, Kelly L, Lengline E, Cabannes-Hamy A, Siavellis J, Ghez D, Sauvageon H, Braun T, Jacqz-Aigrain E, Kohn M, Rousselot P, Puissant A, Raffoux E, Mourah S, Goldwirt L. Vignal N, et al. Among authors: kelly l. Haematologica. 2023 Sep 1;108(9):2531-2534. doi: 10.3324/haematol.2022.282596. Haematologica. 2023. PMID: 36794507 Free PMC article. No abstract available.
INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia Treatment.
Bratti M, Stubbs E, Kolodych S, Souchet H, Kelly L, Merlin J, Marchal M, Castellano R, Josselin E, Pasquer H, Benajiba L, Puissant A, Koniev O, Collette Y, Belanger C, Hermine O, Monteiro RC, Launay P. Bratti M, et al. Among authors: kelly l. Mol Cancer Ther. 2024 Aug 1;23(8):1159-1175. doi: 10.1158/1535-7163.MCT-23-0548. Mol Cancer Ther. 2024. PMID: 38641421
Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule.
Kelly LM, Rutter JC, Lin KH, Ling F, Duchmann M, Latour E, Arang N, Pasquer H, Ho Nhat D, Charles J, Killarney ST, Ang HX, Namor F, Culeux C, Lombard B, Loew D, Swaney DL, Krogan NJ, Brunel L, Carretero É, Verdié P, Amblard M, Fodil S, Huynh T, Sebert M, Adès L, Raffoux E, Fenouille N, Itzykson R, Lobry C, Benajiba L, Forget A, Martin AR, Wood KC, Puissant A. Kelly LM, et al. Nat Cancer. 2024 Jul;5(7):1082-1101. doi: 10.1038/s43018-024-00782-5. Epub 2024 May 30. Nat Cancer. 2024. PMID: 38816660
The Role of Neutrophils in Allergic Disease.
Trayer J, Isaza-Correa JM, Kelly LA, Kelleher M, Hourihane JO, Byrne A, Molloy EJ. Trayer J, et al. Among authors: kelly la. Clin Exp Immunol. 2024 Dec 26:uxae126. doi: 10.1093/cei/uxae126. Online ahead of print. Clin Exp Immunol. 2024. PMID: 39721985
Factors Associated With Return to Activity After Concussion Among Female Service Academy Members: Findings From the NCAA-DoD CARE Consortium.
Jain D, Caccese JB, Boltz AJ, Buckley T, Cameron KL, Chrisman SPD, Clugston JR, Eckner JT, Ermer E, Scott FG, Harcum S, Hunt TN, Jannace KC, Kelly LA, Lempke LB, McDevitt J, Memmini A, Mozel A, Putukian M, Robb JB, Susmarski AJ, Syrydiuk RA, Broglio SP, McAllister TW, McCrea MA, Pasquina PF, Master CL, Esopenko C. Jain D, et al. Among authors: kelly la. Mil Med. 2024 Dec 10:usae527. doi: 10.1093/milmed/usae527. Online ahead of print. Mil Med. 2024. PMID: 39658275
1,913 results